市场调查报告书
商品编码
1500406
医学影像市场:按模式、最终用户、应用划分 - 2024-2030 年全球预测Medical Imaging Market by Modality (Computed Tomography, Fluoroscopy, Mammography), End-User (Diagnostic Centers, Hospitals), Application - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年医学影像市场规模为540.5亿美元,预计2024年将达612.2亿美元,2030年将达1,391亿美元,复合年增长率为14.45%。
医学影像市场是医疗保健的关键支柱,提供复杂的技术来视觉化人体内部解剖结构,这对于诊断、治疗和研究至关重要。市场成长的推动因素包括不断提高影像品质和系统效率的技术进步、需要强大诊断解决方案的慢性疾病的增加、需要频繁医疗服务的老年人口的增加以及对医疗保健基础设施的需求增加,这些因素包括:重大政府投资。然而,医学影像领域也面临重大挑战,包括与先进诊断影像系统相关的高成本、严格的监管条件以及对可能限制患者接触的辐射暴露的担忧。人工智慧的日益整合预计将提高诊断准确性,可携式诊断成像设备的开发提高了可及性,诊断成像技术的进步最大限度地减少了辐射风险,从而提供了市场扩张机会。混合成像技术也正在成为一种创新趋势,融合多种显像模式以提高诊断效率和患者治疗结果。
主要市场统计 | |
---|---|
基准年[2023] | 540.5亿美元 |
预测年份 [2024] | 612.2亿美元 |
预测年份 [2030] | 1391亿美元 |
复合年增长率(%) | 14.45% |
区域洞察
在美洲,美国在研发 (R&D) 方面的大量投资的支持下,重点在于提高诊断成像准确性和减少辐射暴露。受益于政府医疗保健政策和以美国为首的国际合作,加拿大专注于人工智慧和医学影像的融合,正在製定诊断准确性的新标准。在欧盟(EU),成员国受益于一致的法律规范,并专注于医学影像的标准化,从而允许大规模的医疗投资来实现一致的高品质护理。同时,中东和非洲 (MEA) 的情况则截然不同。儘管阿联酋和沙乌地阿拉伯等海湾国家不断增加的医疗投资正在迅速引进先进的诊断影像系统,但非洲许多地区仍难以获得此类技术,只能依靠国际援助来填补这一空白。转向亚太地区,在重大医疗改革和专注于行动和非侵入性成像解决方案的研发部门的推动下,中国正在经历对医疗成像设备的高消费和需求,并迅速成为一个重要的国家,平衡成长。生产。在政府改善医疗保健和研发投资的支持下,日本在高端医学成像技术方面表现出色。印度中产阶级不断壮大,健康意识不断增强,由于政府努力扩大医疗保险覆盖范围,以及专注于创新成像解决方案的蓬勃发展的新兴企业系统,印度有望成为一个重要的国家。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在医学影像市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检查了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可对医疗影像市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外,该分析还提供了对该行业竞争性质的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在医学影像市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[190 Pages Report] The Medical Imaging Market size was estimated at USD 54.05 billion in 2023 and expected to reach USD 61.22 billion in 2024, at a CAGR 14.45% to reach USD 139.10 billion by 2030.
The medical imaging market serves as a crucial pillar within healthcare, offering sophisticated techniques for visualizing internal human anatomy, which is vital for diagnostics, treatment, and research. The market growth is propelled by multiple factors: ongoing technological enhancements that improve image quality and system efficiency, an increase in chronic diseases necessitating robust diagnostic solutions, an expanding elderly population demanding frequent healthcare services, and substantial government investments in healthcare infrastructure. However, the medical imaging sector also navigates significant challenges, such as the high costs associated with advanced imaging systems, stringent regulatory landscapes, and concerns over radiation exposure, which may limit patient usage. Ongoing AI integration promises to refine diagnostic precision, the development of portable imaging devices boost accessibility, and advancements in imaging techniques minimize radiation risks, presenting opportunities for market expansion. Hybrid imaging technologies have also emerged as a revolutionary trend, merging multiple imaging modalities to enhance diagnostic efficiency and patient outcomes.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 54.05 billion |
Estimated Year [2024] | USD 61.22 billion |
Forecast Year [2030] | USD 139.10 billion |
CAGR (%) | 14.45% |
Regional Insights
In the Americas region, the United States has a strong emphasis on enhancing imaging precision and reducing radiation exposure, supported by considerable investments in research and development (R&D). Canada's focus on integrating artificial intelligence with medical imaging is setting new standards for diagnostic accuracy, benefiting from governmental healthcare policies and international collaborations, notably with the U.S. Across the European Union, member states benefit from cohesive regulatory frameworks that drive substantial healthcare investments, focusing on standardizing medical imaging to ensure consistent, high-quality care. Meanwhile, the Middle East and Africa (MEA) depict a contrasting scenario; while Gulf countries such as the UAE and Saudi Arabia rapidly incorporate advanced imaging systems due to increased healthcare investments, many African regions still grapple with basic access to these technologies, relying on international aid to bridge the gap. Turning to the Asia-Pacific region, China is rapidly becoming a pivotal country, balancing high consumption with an increasing production of medical imaging equipment, propelled by significant healthcare reforms and a burgeoning R&D sector focusing on mobile and non-invasive imaging solutions. Japan excels in high-end medical imaging technology, supported by substantial governmental healthcare provision and R&D investments. India, with a rising middle class and heightened health awareness, is emerging as a significant market driven by governmental efforts to expand healthcare coverage and a flourishing start-up ecosystem focusing on innovative imaging solutions.
Market Insights
The market dynamics represent an ever-changing landscape of the Medical Imaging Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Medical Imaging Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Medical Imaging Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Clario and Emsere Form Strategic Alliance to Enhance Ophthalmic Clinical Trials
Clario, a company in endpoint solutions for clinical trials, is excited to announce its strategic partnership with Emsere, a renowned supplier of medical equipment. This partnership is set to revolutionize the execution of clinical trials involving ophthalmic imaging and equipment by providing a seamless, integrated solution. Leveraging Emsere's global reach and Clario's extensive trial expertise, the partnership aims to address the equipment scarcity at various trial sites, thereby enhancing the overall trial efficiency. [Published On: 2024-05-21]
Enhancing Medical Innovations, A Collaborative Initiative for Streamlined Access to High-Quality Medical Imaging Data
The U.S. Department of Health and Human Services has launched an innovative partnership through the Advanced Research Projects Agency for Health (ARPA-H) and the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA). This joint initiative aims to develop a Medical Imaging Data Marketplace (MIDM) that would provide widespread access to high-quality and affordable medical imaging data crucial for training Artificial Intelligence (AI) and Machine Learning (ML) in medical diagnostics and treatment tools. [Published On: 2024-03-12]
Philips Unveils Cutting-Edge Medical Imaging Solutions, Enhancing Diagnostic Confidence and Operational Efficiency
Royal Philips introduced several pioneering technologies poised to transform medical imaging practices, emphasizing patient and provider needs. The showcased innovations included advanced ultrasound systems such as EPIQ Elite 10.0 and Philips Affiniti, which integrate sophisticated features in user-friendly designs to aid sonographers in daily practices. Additionally, the revolutionary BlueSeal MR Mobile, mobile MRI unit with helium-free technology is launched, aimed at delivering flexible, patient-centric diagnostic services, while significantly reducing helium consumption as a notable advancement considering the environmental and economic impacts. [Published On: 2023-11-26]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Medical Imaging Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Medical Imaging Market, highlighting leading vendors and their innovative profiles. These include ADLINK Technology Inc., Advantech Co., Ltd., Ampronix, LLC, Aspect Imaging Ltd., Canon Medical Systems Corporation, Carestream Health, Cubresa Inc., EIZO Corporation, ESAOTE SPA, FUJIFILM VisualSonics Inc., GE Healthcare, Hitachi Ltd., Hologic, Inc., Koning Corporation, Koninklijke Philips N.V., Mindray Medical International Limited, MR Solutions Ltd., Olympus Corporation, PerkinElmer Inc., Samsung Healthcare, Shimadzu Corporation, Siemens Healthineers AG, Smith & Nephew PLC, TEAC Corporation, and Ziehm Imaging Inc..
Market Segmentation & Coverage